Sheila Morris - Concepedia

Author

Sheila Morris

Also Known As

Alasdair Bamford, Ana Alvaro, Andrew Kerr, Clifford Leen, Emily Beech, Jeremy Scanlon, Morris, S, S Morris, S. D. Morris, Sheila Morris

Publications

11.8K

Citations

H-Index

Concepts

All Affiliations

University of Bristol University of Oxford University College London Guy's and St Thomas' NHS Foundation Trust King's College London

About

Sheila Morris is an author at University of Bristol specializing in medicine, covid-19, and antibiotics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	955
2	Public Health	1	1	18
3	Epidemiology	1	1	18
4	Global Health	1	1	18
5	Hospital Medicine	1	1	555

Sheila Morris

Publications

9.6K

Citations

H-Index

Page 1

	Year	Citations
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi, The Lancet	2020	5K
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi, The Lancet	2021	1.2K
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study Alison Rodger, Valentina Cambiano, Tina Bruun, The Lancet	2019	966
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi, The Lancet Long CovidAntimicrobial StewardshipAntibioticsClinical InfectionPlatform Trial	2021	555
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	516
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet Covid-19 PandemicAntiviral TherapyClinical TrialsPlatform TrialMedicine	2022	382
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	289
Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19 Hesham Abdelhady, Marwa Abdelrazik, Zakee Abdi, JAMA	2021	208
Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19 Simin Florescu, Delia Stanciu, Mihaela Zaharia, JAMA	2022	147
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial Simin Florescu, Delia Stanciu, Mihaela Zaharia, JAMA	2022	133

Page 1